Radiotherapy plus hormone therapy halved prostate cancer mortality

The addition of radiation therapy to antiandrogen therapy halved the 10- and 15-year rates for mortality among men with high-risk nonmetastatic prostate cancer compared with hormone therapy alone, according to updated study results presented at the 2014 Genitourinary Cancers Symposium.

Healio